Autobahn begins dosing in Phase I major depressive disorder treatment trial
An oral TRβ agonist, ABX-002 had shown target engagement in areas of the brain linked to depression.
News
VIDA introduces updated platform for clinical trial imaging operations
Exscientia receives approval to begin advanced solid tumour therapy trial
Cancer Research UK and Stitch to pilot app for patients in trials
Anticoagulant unbeneficial for Covid-19 University of Cambridge trial finds
Almirall to take part in FACILITATE project to enable trial data usage
US FDA lifts partial clinical suspension on Diamyd’s diabetes therapy trial
Australian researchers commence Phase I strep A vaccine trial
Subscribe to our Newsletter
Get industry leading news, data and analysis delivered to your inbox
